[1] Bosch FX, Lorincz A, Mu?oz N,et al. The causal re-lation between human papillomavirus andcervical cancer [J]. J Clin Pathol, 2002,55(4):244-265.[2] Forman D, de Martel C, Lacey CJ,et al. Global burden of human papillomavirus and related diseases [J]. Vaccine, 2012,30(5):F12-F23. [3] Dunne EF, Unger ER, Sternberg M,et al. Prevalence of HPV infection among females in the United States [J]. JA-MA,2007,297(8):813-819. [4] Partridge EE, Abu-Rustum N, Giuliano A,et al. Cervi-cal cancer screening [J]. J Natl Compr Canc Netw, 2014, 12(3):333-341. [5] Jeronimo J, Schiffman M. Colposcopy at a crossroads [J]. Am J Obstet Gynecol,2006,195(2):349-353. [6] 钟彩香.HPV、TCT检查联合电子阴道镜下宫颈活检在宫颈癌前 病变及宫颈癌中的诊断价值[J].福建医药杂志,2018,40(5):54-56. [7] Bornstein J, Bentley J, B?sze P, et al. 2011 colposcopic terminology of the International Federation for Cervical Pa-thology and Colposcopy [J]. Obstet Gynecol, 2012,120(1): 166-172. [8] US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Cervical Cancer: US Preventive Servic-es Task Force Recommendation Statement [J]. JAMA, 2018,320(7):674-686. [9] 丰颖,唐丽娟,曾良,等.HR-HPV、TCT联合电子阴道镜下宫颈 活检在宫颈癌前病变及宫颈癌诊断中的应用[J].实用临床医学, 2015,121(1):61-63,76. [10] 纪巧云,刘美霞,侯玉兰,等.阴道镜下宫颈活组织检测在宫颈癌 筛查中的临床应用研究[J].中国病案,2019,20(3):109-112. [11] 孙斯媛,罗飞,胡义忠,等.HPV、TCT及活检在宫颈病变筛查中 的应用研究[J].河北医药,2019,41(11):1645-1649.